Faculty profile

David Berman

ResearcherSurgeryQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

David Berman

Researcher

Surgery

Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

159

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Mass Spectrometry Metabolomic Imaging Robotics Surgery Surgical Navigation

Latest papers

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.
Cancers · 2026
Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.
European urology open science · 2021
Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.
European urology open science · 2020

All 12 publications

Latest funding

Role of trained immunity in the response to BCG immunotherapy of bladder cancer
CIHR · 2020 · Co-investigator
$1,086,300
Robotic breast cancer surgery
NSERC · 2020 · Co-investigator
$351,712
Robotically assisted real-time metabolomic navigation of breast conserving surgery
CIHR · 2019 · Principal investigator
$337,724

All 3 grants and awards

12 publications.

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Seung SJ, Bayani J, Nguyen L, Liu N, Gatley J, Wong A, Richard E, Barker SL, Lee AY, Bartlett JMS, Berman D, Loblaw A, Earle CC, Mittmann N

Cancers2026

DOI: 10.3390/cancers18101580 PMID: 42192940

Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.

Chenard S, Jackson C, Vidotto T, Chen L, Hardy C, Jamaspishvilli T, Berman D, Siemens DR, Koti M

European urology open science2021

DOI: 10.1016/j.euros.2021.05.002 PMID: 34337534

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.

Khalid S, Basulaiman BM, Emack J, Booth CM, Duran I, Robinson AG, Berman D, Smoragiewicz M, Amir E, Vera-Badillo FE

European urology open science2020

DOI: 10.1016/j.euros.2020.08.008 PMID: 34337469

Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.

Ebrahimizadeh W, Guérard KP, Rouzbeh S, Bramhecha YM, Scarlata E, Brimo F, Patel PG, Jamaspishvili T, Aprikian AG, Berman D, Bartlett JMS, Chevalier S, Lapointe J

The Journal of molecular diagnostics : JMD2020

DOI: 10.1016/j.jmoldx.2020.07.003 PMID: 32763409

Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.

Black PC, Alimohamed NS, Berman D, Blais N, Eigl B, Karakiewicz PI, Kassouf W, Kulkarni GS, Ong M, Spatz A, Sridhar SS, Stockley T, van der Kwast T, Hew H, Park-Wyllie L, North SA

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2020

DOI: 10.5489/cuaj.6458 PMID: 32209217

Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up

Klotz L, Pond G, Loblaw A, Sugar L, Moussa M, Berman D, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M

European Urology2020159 citations

DOI: 10.1016/j.eururo.2019.10.007 PMID: W2984399591

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.

Roberto D, Selvarajah S, Park PC, Berman D, Venkateswaran V

The Prostate2019

DOI: 10.1002/pros.23903 PMID: 31503357

Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.

Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan GA, Athanazio D, Abro S, Visram K, Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf W, Trpkov K

Histopathology2018

DOI: 10.1111/his.13654 PMID: 29776013

Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.

Siemens DR, Mackillop WJ, Peng Y, Wei X, Berman D, Booth CM

Urologic oncology2015

DOI: 10.1016/j.urolonc.2015.06.005 PMID: 26199175

Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma.

Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, Schoenberg M, Hahn N, Hoque MO, Berman D, Bivalacqua TJ, Netto G

PloS one2015

DOI: 10.1371/journal.pone.0131245 PMID: 26230923

Something wrong or missing on this profile? Suggest a correction

David Berman

Research

Latest papers

Latest funding

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.

Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.

Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.

Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.

Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.

Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.

Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma.

Role of trained immunity in the response to BCG immunotherapy of bladder cancer

Robotic breast cancer surgery

Robotically assisted real-time metabolomic navigation of breast conserving surgery

Frequent collaborators

Andrew Loblaw

Wassim Kassouf

Bernhard Eigl

Nicole Mittmann

Michael Ong

Eitan Amir

Ning Liu

Robert Siemens

Tracy Stockley

Gregory Pond

Vasundara Venkateswaran

Madhuri Koti

Neil Fleshner